S

eeking to toughen the Sunshine Act, Sen. Claire McCaskill (D-Mo.) plans to introduce a bill that would require drug makers to report payments that are made to nonprofit organizations and patient advocacy groups, according to several sources familiar with the effort.

The move comes eight years after the Sunshine Act was created in response to concerns that industry payments were unduly influencing medical research and practice, an issue that arose after a Senate Finance Committee probe. The law was subsequently folded into the Affordable Care Act and a federal database was launched in 2014 to which companies must report payments to physicians.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy